Your browser doesn't support javascript.
loading
ERG amplification is a secondary recurrent driver event in myeloid malignancy with complex karyotype and TP53 mutations.
Lee, Winston Y; Gutierrez-Lanz, Efrain A; Xiao, Hong; McClintock, David; Chan, May P; Bixby, Dale L; Shao, Lina.
Affiliation
  • Lee WY; Department of Pathology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Gutierrez-Lanz EA; Department of Pathology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Xiao H; Department of Pathology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • McClintock D; Department of Pathology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Chan MP; Department of Pathology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Bixby DL; Division of Hematology and Medical Oncology, Department of Medicine, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • Shao L; Department of Pathology, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Genes Chromosomes Cancer ; 61(7): 399-411, 2022 07.
Article in En | MEDLINE | ID: mdl-35083818

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Myeloproliferative Disorders Type of study: Prognostic_studies Limits: Humans / Male Language: En Journal: Genes Chromosomes Cancer Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2022 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Myeloproliferative Disorders Type of study: Prognostic_studies Limits: Humans / Male Language: En Journal: Genes Chromosomes Cancer Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2022 Type: Article Affiliation country: United States